Carla Leibowitz is a growth and innovation executive currently leading Corporate Development Arterys, the first company to achieve FDA clearances for several products and a platform that combine cloud computing and artificial intelligence in the medical imaging space. In her role, Carla oversees corporate strategy and planning, business development, geographic expansion and investor relations. She has an MBA from the Stanford Graduate School of Business and engineering degrees from both MIT and Stanford. Prior to joining Arterys, Carla spent 3 years at Bain & Company, consulting for top biotech, diagnostic and hospital clients. Before to that, Carla designed medical devices and led device development teams at several companies and has more than 16 patents under her name.


Speaker at MedtechVISION 2018 – Panel 2: The Broader Impact of Regulating AI: Keeping up with innovation in a complex regulatory landscape

Note: Speaker biographies were written at time of speaking engagement and may not reflect their current job title and position.
View All
Connect With Carla